Evolent Health Acquires NIA (Magellan Specialty Health) from Centene

November 17, 2022

Evolent Health has entered into a definitive agreement to acquire NIA (also known as Magellan Specialty Health), the specialty benefit management business owned by Centene. The deal provides $650 million in upfront consideration plus up to $150 million of contingent consideration; Evolent expects revenue and EBITDA synergies and to fully integrate NIA into its value-based specialty care platform.

Buyers
Evolent Health
Targets
NIA (Magellan Specialty Health)
Sellers
Centene Corporation
Location
United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.